Stockscreener 앱 받기
25.14
3.54%
0.86
시간 외 거래:
25.06
-0.08
-0.32%
전일 마감가:
$24.28
열려 있는:
$24.66
하루 거래량:
13.00M
Relative Volume:
1.41
시가총액:
$9.78B
수익:
$3.14B
순이익/손실:
$-3.36B
주가수익비율:
-2.8797
EPS:
-8.73
순현금흐름:
$-4.03B
1주 성능:
+4.36%
1개월 성능:
-8.48%
6개월 성능:
-28.60%
1년 성능:
-65.77%
1일 변동 폭
$24.61
$25.48
1주일 범위
$23.33
$25.48
52주 변동 폭
$23.15
$79.96
모더나 Stock (MRNA) Company Profile
명칭
Moderna Inc
전화
(617) 714-6500
주소
325 BINNEY STREET, CAMBRIDGE
MRNA을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
MRNA
Moderna Inc
|
25.14 | 9.45B | 3.14B | -3.36B | -4.03B | -8.73 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.12 | 101.77B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
573.38 | 60.12B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
452.00 | 59.45B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
750.78 | 44.90B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
341.80 | 35.07B | 3.81B | -644.79M | -669.77M | -6.24 |
모더나 Stock (MRNA) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-03-13 | 개시 | Citigroup | Neutral |
| 2025-02-18 | 다운그레이드 | Barclays | Overweight → Equal Weight |
| 2025-01-29 | 다운그레이드 | Goldman | Buy → Neutral |
| 2024-12-18 | 다운그레이드 | Argus | Buy → Hold |
| 2024-12-10 | 재개 | BofA Securities | Underperform |
| 2024-11-19 | 개시 | Berenberg | Hold |
| 2024-11-18 | 업그레이드 | HSBC Securities | Hold → Buy |
| 2024-11-15 | 개시 | Wolfe Research | Underperform |
| 2024-10-17 | 개시 | Bernstein | Mkt Perform |
| 2024-09-13 | 다운그레이드 | JP Morgan | Neutral → Underweight |
| 2024-09-13 | 다운그레이드 | Jefferies | Buy → Hold |
| 2024-09-13 | 다운그레이드 | Oppenheimer | Outperform → Perform |
| 2024-08-28 | 업그레이드 | HSBC Securities | Reduce → Hold |
| 2024-08-07 | 업그레이드 | Deutsche Bank | Sell → Hold |
| 2024-08-05 | 다운그레이드 | RBC Capital Mkts | Outperform → Sector Perform |
| 2024-02-26 | 다운그레이드 | HSBC Securities | Hold → Reduce |
| 2024-01-02 | 업그레이드 | Oppenheimer | Perform → Outperform |
| 2023-11-29 | 개시 | Canaccord Genuity | Hold |
| 2023-11-03 | 업그레이드 | HSBC Securities | Reduce → Hold |
| 2023-11-02 | 다운그레이드 | Deutsche Bank | Hold → Sell |
| 2023-08-04 | 다운그레이드 | TD Cowen | Outperform → Market Perform |
| 2023-08-03 | 다운그레이드 | Deutsche Bank | Buy → Hold |
| 2023-07-24 | 개시 | William Blair | Mkt Perform |
| 2023-07-14 | 개시 | HSBC Securities | Reduce |
| 2023-06-26 | 업그레이드 | UBS | Neutral → Buy |
| 2023-04-26 | 개시 | Guggenheim | Neutral |
| 2023-03-13 | 업그레이드 | TD Cowen | Market Perform → Outperform |
| 2023-03-02 | 개시 | RBC Capital Mkts | Outperform |
| 2023-02-24 | 다운그레이드 | SVB Securities | Market Perform → Underperform |
| 2022-12-19 | 업그레이드 | Jefferies | Hold → Buy |
| 2022-12-14 | 다운그레이드 | Chardan Capital Markets | Buy → Neutral |
| 2022-10-21 | 업그레이드 | SVB Leerink | Underperform → Mkt Perform |
| 2022-09-08 | 업그레이드 | Deutsche Bank | Hold → Buy |
| 2022-02-01 | 업그레이드 | Redburn | Sell → Neutral |
| 2022-01-26 | 업그레이드 | Deutsche Bank | Sell → Hold |
| 2022-01-21 | 업그레이드 | BofA Securities | Underperform → Neutral |
| 2022-01-21 | 개시 | UBS | Neutral |
| 2021-12-07 | 개시 | Cowen | Market Perform |
| 2021-11-09 | 개시 | Wolfe Research | Outperform |
| 2021-10-22 | 개시 | Deutsche Bank | Sell |
| 2021-10-15 | 업그레이드 | Piper Sandler | Neutral → Overweight |
| 2021-08-06 | 다운그레이드 | Oppenheimer | Outperform → Perform |
| 2021-08-06 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2021-07-15 | 재확인 | Jefferies | Hold |
| 2021-02-01 | 다운그레이드 | BofA Securities | Neutral → Underperform |
| 2020-12-16 | 다운그레이드 | Jefferies | Buy → Hold |
| 2020-12-16 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2020-12-09 | 다운그레이드 | Needham | Buy → Hold |
| 2020-11-23 | 개시 | Wells Fargo | Equal Weight |
| 2020-11-17 | 다운그레이드 | BMO Capital Markets | Outperform → Market Perform |
| 2020-09-08 | 다운그레이드 | SVB Leerink | Mkt Perform → Underperform |
| 2020-07-23 | 개시 | SVB Leerink | Mkt Perform |
| 2020-07-20 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2020-07-13 | 개시 | Jefferies | Buy |
| 2020-06-30 | 개시 | Argus | Buy |
| 2020-06-08 | 개시 | Barclays | Overweight |
| 2020-04-30 | 개시 | BMO Capital Markets | Outperform |
| 2020-03-05 | 다운그레이드 | BofA/Merrill | Buy → Neutral |
| 2019-12-03 | 재개 | BofA/Merrill | Buy |
| 2019-10-25 | 개시 | ROTH Capital | Buy |
| 2019-04-05 | 개시 | Chardan Capital Markets | Buy |
모두보기
모더나 주식(MRNA)의 최신 뉴스
H&H International Investment LLC Sells 80,000 Shares of Moderna, Inc. $MRNA - MarketBeat
Moderna Announces Data to be Presented at the 2025 International Congress of Inborn Errors of Metabolism - Pensacola News Journal
Vaccine chaos: Even some vulnerable seniors can’t get COVID shots amid spiking cases - Los Angeles Times
Nomura Holdings Inc. Purchases 15,938 Shares of Moderna, Inc. $MRNA - MarketBeat
Canada Pension Plan Investment Board Sells 86,135 Shares of Moderna, Inc. $MRNA - MarketBeat
Should you avoid Moderna Inc. stock right nowJuly 2025 EndofMonth & Weekly Top Stock Performers List - خودرو بانک
What’s the outlook for Moderna Inc.’s sectorInflation Watch & Daily Stock Trend Watchlist - خودرو بانک
Smart Money: Can Moderna Inc. deliver alphaWeekly Stock Recap & Growth Oriented Trade Recommendations - خودرو بانک
Moderna, Inc. shares rise 2.72% intraday after U.S. FDA independently recommends virus strains for 2025-2026 influenza vaccines. - AInvest
Banque Transatlantique SA Purchases 42,107 Shares of Moderna, Inc. $MRNA - MarketBeat
Moderna Inc. stock trendline breakdownQuarterly Performance Summary & Fast Entry and Exit Trade Plans - Newser
Moderna Inc. stock outlook for YEARStop Loss & Verified Momentum Stock Watchlist - Newser
Risk adjusted return profile for Moderna Inc. analyzedTrade Entry Summary & Safe Investment Capital Preservation Plans - Newser
Is Moderna Inc. still worth holding after the dipJuly 2025 Decliners & Low Risk High Reward Ideas - Newser
GSK Adds Moderna's New COVID Vaccine To Del. IP Suit - Law360
Can Moderna Inc. rally from current levels2025 Price Momentum & Reliable Trade Execution Plans - Newser
What moving averages say about Moderna Inc.Portfolio Growth Summary & Real-Time Market Trend Scan - Newser
Moderna’s New mNexspike Covid Shot Pulled Into GSK Patent Suit - Bloomberg Law News
RFK Jr. seeks to replace CDC vaccine panel members againreport - Seeking Alpha
Stock Analysis | Moderna OutlookA Mixed Bag for MRNA: Analysts Split as Technicals Signal Weakness - AInvest
Comerica Bank Purchases 29,020 Shares of Moderna, Inc. $MRNA - MarketBeat
Robert F. Kennedy Jr.'s Vaccine Shake-Up Sparks Coast-To-Coast Divide: West Coast Creates Health Alliance, Florida Rolls Back Requirements - Benzinga
Florida Chooses 'Medical Freedom' As State Plans To End Vaccine Mandates, Even For Schools: Experts Warn Of 'Major Disaster' - Benzinga
Florida plans to end all state vaccine mandates, including for schools - MarketScreener
Pfizer, Moderna, Novavax respond to Trump’s criticism of COVID shot success - Seeking Alpha
Pfizer, Moderna defend COVID vaccine effectiveness after Trump remarks - Reuters
Florida to eliminate all state vaccine mandates, surgeon general says - Seeking Alpha
Moderna's mRNA Technology Remains Valuable but Covid Vaccine Headwinds Create Pressure - Morningstar
Moderna : Recognizes the Success of Operation Warp Speed and its Ongoing Commitment to Transparency - MarketScreener
West Coast states launch health alliance amid changes at CDC - Seeking Alpha
Moderna (MRNA) Receives a Hold from Argus Research - The Globe and Mail
Measuring Moderna Inc.’s beta against major indicesJuly 2025 Action & Weekly Breakout Watchlists - Newser
PDT Partners LLC Has $6.21 Million Position in Moderna, Inc. $MRNA - MarketBeat
SHANDA ASSET MANAGEMENT HOLDINGS Ltd Takes Position in Moderna, Inc. $MRNA - MarketBeat
Volume spikes in Moderna Inc. stock – what they meanPortfolio Gains Report & Community Driven Trade Alerts - Newser
Quotient Sciences and CPI to expedite RNA therapy development - Pharmaceutical Technology
Published on: 2025-09-03 04:00:37 - Newser
Moderna Inc. (NASDAQ: MRNA) Shares Rally 0.42% as Oncology Advances and Rare Disease Trials Fuel Optimism - AInvest
Moderna Inc. stock daily chart insightsLong Setup & Weekly Top Gainers Alerts - Newser
Has Moderna Inc. formed a bullish divergence2025 Investor Takeaways & AI Enhanced Trading Signals - Newser
FDA quietly positions itself to disrupt childhood vaccine schedule - BioCentury
Can Moderna Inc. disrupt its industry2025 Analyst Calls & Community Consensus Trade Alerts - خودرو بانک
Price action breakdown for Moderna Inc.2025 Bull vs Bear & AI Powered Buy and Sell Recommendations - Newser
South Korea clears Moderna’s Spikevax LP.8.1 vaccine for COVID-19 - BioWorld MedTech
How hedge fund analytics apply to Moderna Inc. stockEntry Point & Fast Moving Market Watchlists - Newser
Pfizer, Moderna, and the Political-Economic Fallout from Trump's Data Demands on COVID Vaccines - AInvest
Detecting support and resistance levels for Moderna Inc.Weekly Loss Report & AI Based Buy/Sell Signal Reports - Newser
Pfizer, Moderna in focus as Trump demands answers on COVID success - Seeking Alpha
First-Ever Data: Moderna's Revolutionary mRNA Treatments for Three Rare Metabolic Diseases at ICIEM 2025 - Stock Titan
Is Moderna Stock Underperforming the S&P 500? - MSN
Is Moderna Stock Underperforming The S&P 500? - Barchart.com
모더나 (MRNA) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.40%
자본화:
|
볼륨(24시간):